Navigation Links
A Stroke of Bad Luck for Vioxx

The anti-inflammatory drug Vioxx has been in the news for the wrong reasons and now scientists seem to have more clarity regarding Vioxx and the causative agent of the side-//effects. The answer hovers around the vital property of the drug - the blood clotting mechanism, British scientists reveal.

These drugs known as COX-2 inhibitors are most often used to alleviate pain in chronic conditions like arthritis. The drugs achieve its purpose by hampering the function of the COX-2 enzyme, present in the inflamed areas. The medications also halt the COX-1 enzyme, found in the lining of blood vessels.

In 2004, Vioxx was recalled from the market due to perceived health risks. Prof. Jane Mitchell from the National Heart and Lung Institute at Imperial College London and her colleagues are of the opinion that blocking the COX-1 enzyme may result in clotting of blood. And, if the drugs are consumed in regular doses, this could enhance the risk of stroke or heart attack.

'Our new research is exciting because it means we can work on developing better COX-2 inhibitors that don't pose the same risks in terms of heart attacks and strokes,' Mitchell said.

Researchers had all along believed that COX-2 inhibitors caused the blockage of the COX-2 enzyme in the endothelium, triggering the adverse reaction. This study has lent a valuable insight, which is the absence of COX-2 enzyme in the endothelium and the presence of COX-1 enzyme, which is the reason behind the adverse side-effect. Impediments to the COX-1 enzyme could result in clots, that may trigger the adverse reaction, scientists said.
SAV
'"/>




Page: 1

Related medicine news :

1. Amphetamines Help Recovery of Stroke Patients
2. Cough Syrup Ingredient Linked to Stroke
3. Estrogen Does Not Prevent Recurrent Strokes
4. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
5. Triglycerides Linked To Stroke Risk
6. Strokes increased during squatting
7. Drug Combinations May Boost Stroke Risk
8. Stroke and Dementia - a ghastly association
9. Stroke risk might be linked to antibody
10. Stroke Risk and Fish :A factual interconnection
11. Fewer teeth & Increased Ischemic Stroke risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... ... and financial planning assistance to clients in southern Montana, is announcing a focused ... Zoo Montana. , The outreach programs offered by Zoo Montana provide students with ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Excel Medical, the ... to the position of Executive Vice President, Sales and Marketing. Finnegan is a ... and medical device sales leadership. He has received industry recognition for innovations and ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
Breaking Medicine News(10 mins):
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
(Date:5/30/2017)... Holdings, Inc. (NYSE: HRC), will present at the Goldman Sachs ... 13, 2017, in Rancho Palos Verdes, California ... officer, is scheduled to present at 3:20 p.m. Pacific Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one ... 2017. About Hill-Rom ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
Breaking Medicine Technology: